162 related articles for article (PubMed ID: 17885951)
1. Efficacy of caspofungin and posaconazole in a murine model of disseminated Exophiala infection.
Rivard RG; McCall S; Griffith ME; Hawley JS; Ressner RA; Borra H; Moon JE; Beckius ML; Murray CK; Hospenthal DR
Med Mycol; 2007 Dec; 45(8):685-9. PubMed ID: 17885951
[TBL] [Abstract][Full Text] [Related]
2. Comparison of antifungal treatments for murine fusariosis.
Spellberg B; Schwartz J; Fu Y; Avanesian V; Adler-Moore J; Edwards JE; Ibrahim AS
J Antimicrob Chemother; 2006 Nov; 58(5):973-9. PubMed ID: 16973654
[TBL] [Abstract][Full Text] [Related]
3. Experimental treatment of Curvularia infection.
Paredes K; Capilla J; Sutton DA; Mayayo E; Fothergill AW; Guarro J
Diagn Microbiol Infect Dis; 2014 Aug; 79(4):428-31. PubMed ID: 24938759
[TBL] [Abstract][Full Text] [Related]
4. Posaconazole therapy of disseminated phaeohyphomycosis in a murine model.
Graybill JR; Najvar LK; Johnson E; Bocanegra R; Loebenberg D
Antimicrob Agents Chemother; 2004 Jun; 48(6):2288-91. PubMed ID: 15155236
[TBL] [Abstract][Full Text] [Related]
5. Experimental systemic murine aspergillosis: treatment with polyene and caspofungin combination and G-CSF.
Sionov E; Mendlovic S; Segal E
J Antimicrob Chemother; 2005 Sep; 56(3):594-7. PubMed ID: 16006446
[TBL] [Abstract][Full Text] [Related]
6. Antifungal therapies in murine disseminated phaeohyphomycoses caused by Exophiala species.
Calvo E; Pastor FJ; Guarro J
J Antimicrob Chemother; 2010 Jul; 65(7):1455-9. PubMed ID: 20488983
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the kidney fungal burden in experimental disseminated candidiasis by species of the Candida parapsilosis complex treated with fluconazole, amphotericin B and caspofungin in a temporarily neutropenic murine model.
Szilágyi J; Földi R; Gesztelyi R; Bayegan S; Kardos G; Juhász B; Majoros L
Chemotherapy; 2012; 58(2):159-64. PubMed ID: 22626860
[TBL] [Abstract][Full Text] [Related]
8. The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin.
Mariné M; Bom VL; de Castro PA; Winkelstroter LK; Ramalho LN; Brown NA; Goldman GH
Virulence; 2015; 6(5):476-86. PubMed ID: 25751127
[TBL] [Abstract][Full Text] [Related]
9. Combined therapy in treatment of murine infection by Fusarium solani.
Ruíz-Cendoya M; Mariné M; Guarro J
J Antimicrob Chemother; 2008 Sep; 62(3):543-6. PubMed ID: 18495651
[TBL] [Abstract][Full Text] [Related]
10. Posaconazole activity against Candida glabrata after exposure to caspofungin or amphotericin B.
Spreghini E; Maida CM; Milici ME; Scalise G; Barchiesi F
Antimicrob Agents Chemother; 2008 Feb; 52(2):513-7. PubMed ID: 18056279
[TBL] [Abstract][Full Text] [Related]
11. Antifungal susceptibility testing of Exophiala spp.: a head-to-head comparison of amphotericin B, itraconazole, posaconazole and voriconazole.
Fothergill AW; Rinaldi MG; Sutton DA
Med Mycol; 2009 Feb; 47(1):41-3. PubMed ID: 19107637
[TBL] [Abstract][Full Text] [Related]
12. Posaconazole efficacy in a murine disseminated infection caused by Paecilomyces lilacinus.
Rodríguez MM; Pastor FJ; Serena C; Guarro J
J Antimicrob Chemother; 2009 Feb; 63(2):361-4. PubMed ID: 19054804
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic efficacy of posaconazole in a murine model of disseminated trichosporonosis.
Treviño-Rangel Rde J; López LJ; Palma-Nicolás JP; Hernández-Bello R; González JG; González GM
J Antimicrob Chemother; 2014 Apr; 69(4):1075-8. PubMed ID: 24252752
[TBL] [Abstract][Full Text] [Related]
14. Virulence and Resistance to Antifungal Therapies of Scopulariopsis Species.
Paredes K; Capilla J; Mayayo E; Guarro J
Antimicrob Agents Chemother; 2016 Apr; 60(4):2063-8. PubMed ID: 26787688
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of amphotericin B or amphotericin B-intralipid in combination with caspofungin against experimental aspergillosis.
Sionov E; Mendlovic S; Segal E
J Infect; 2006 Aug; 53(2):131-9. PubMed ID: 16360214
[TBL] [Abstract][Full Text] [Related]
16. In vitro antifungal susceptibility of filamentous fungi causing rare infections: synergy testing of amphotericin B, posaconazole and anidulafungin in pairs.
Drogari-Apiranthitou M; Mantopoulou FD; Skiada A; Kanioura L; Grammatikou M; Vrioni G; Mitroussia-Ziouva A; Tsakris A; Petrikkos G
J Antimicrob Chemother; 2012 Aug; 67(8):1937-40. PubMed ID: 22535624
[TBL] [Abstract][Full Text] [Related]
17. Activity of aminocandin (IP960) compared with amphotericin B and fluconazole in a neutropenic murine model of disseminated infection caused by a fluconazole-resistant strain of Candida tropicalis.
Warn PA; Sharp A; Morrissey G; Denning DW
J Antimicrob Chemother; 2005 Sep; 56(3):590-3. PubMed ID: 16046462
[TBL] [Abstract][Full Text] [Related]
18. Murine model of a disseminated infection by the novel fungus Fonsecaea monophora and successful treatment with posaconazole.
Calvo E; Pastor FJ; Rodríguez MM; Mayayo E; Salas V; Guarro J
Antimicrob Agents Chemother; 2010 Feb; 54(2):919-23. PubMed ID: 20008773
[TBL] [Abstract][Full Text] [Related]
19. Caspofungin: a major breakthrough in treatment of systemic fungal infections.
Agarwal MB; Rathi SA; Ratho N; Subramanian R
J Assoc Physicians India; 2006 Dec; 54():943-8. PubMed ID: 17334012
[TBL] [Abstract][Full Text] [Related]
20. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.
Espinel-Ingroff A
Rev Iberoam Micol; 2003 Dec; 20(4):121-36. PubMed ID: 15456349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
